
Sign up to save your podcasts
Or
Latest real-world evidence with long-durability therapies for neovascular age-related macular degeneration (AMD) and diabetic macular edema (DME).
Credit available for this activity expires: 10/23/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/997563?ecd=bdc_podcast_libsyn_mscpedu
4
77 ratings
Latest real-world evidence with long-durability therapies for neovascular age-related macular degeneration (AMD) and diabetic macular edema (DME).
Credit available for this activity expires: 10/23/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/997563?ecd=bdc_podcast_libsyn_mscpedu
131 Listeners
13 Listeners
323 Listeners
863 Listeners
493 Listeners
694 Listeners
18 Listeners
277 Listeners
254 Listeners
3,322 Listeners
258 Listeners
87 Listeners
1,084 Listeners
186 Listeners
513 Listeners
350 Listeners
59 Listeners
25 Listeners
286 Listeners